Anna Binkiewicz-Glińska

Anna Binkiewicz-Glińska

Auto-generated profile, based on publicly available information

Anna Binkiewicz-Glińska

Department of Rehabilitation, Medical University of Gdansk, Poland,

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2013 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
ABAnna Binkiewicz-Glinska
Anna Binkiewicz-Glinska
ASAgnieszka Sobierajska-Rek
Agnieszka Sobierajska-Rek
SBStanislaw Bakula
Stanislaw Bakula
JWJolanta Maria Wierzba
Jolanta Maria Wierzba
KDKonrad Drewek
Konrad Drewek
KZKatarzyna Zaborowska-Sapeta
Katarzyna Zaborowska-Sapeta
Arthrogryposis multiplex congenita is an etiopathogenetically heterogeneous disorder characterised by non-progressive multiple intra-articular contractures, which can be recognised at birth. The frequency is estimated at 1 in 3,000 newborns. Etiopathogenesis of arthrogryposis is multifactorial.

24 December 2014 in Psychiatria Polska
Verified
Journal Article
Closed access
ABAnna Binkiewicz-Glińska
Anna Binkiewicz-Glińska
SBStanisław Bakuła
Stanisław Bakuła
HTHanna Tomczak
Hanna Tomczak
JLJerzy Landowski
Jerzy Landowski
KRKatarzyna Ruckemann-Dziurdzińska
Katarzyna Ruckemann-Dziurdzińska
WKWojciech Piotr Kiebzak
Wojciech Piotr Kiebzak
According to American College of Rheumatology fibromyalgia syndrome (FMS) is a common health problem characterized by widespread pain and tenderness. The pain and tenderness, although chronic, present a tendency to fluctuate both in intensity and location around the body. Patients with FMS experience fatigue and often have sleep disorders. It is estimated that FMS affects two to four percent of the general population. It is most common in women, though it can also occur in men. FMS most often first occur in the middle adulthood, but it can start as early as in the teen years or in the old age. The causes of FMS are unclear. Various infectious agents have recently been linked with the development of FMS. Some genes are potentially linked with an increased risk of developing FMS and some other health problems, which are common comorbidities to FMS. It is the genes that determine individual sensitivity and reaction to pain, quality of the antinociceptive system and complex biochemistry of pain sensation. Diagnosis and therapy may be complex and require cooperation of many specialists. Rheumatologists often make the diagnosis and differentiate FMS with other disorders from the rheumatoid group. FMS patients may also require help from the Psychiatric Clinic (Out-Patients Clinic) due to accompanying mental problems. As the pharmacological treatment options are limited and only complex therapy gives relatively good results, the treatment plan should include elements of physical therapy.

1 January 2015
Verified
Journal Article
Closed access
ABAnna Binkiewicz-Glińska
Anna Binkiewicz-Glińska
KRKatarzyna Ruckermann-Dziurdzińska
Katarzyna Ruckermann-Dziurdzińska

13 December 2016
Verified
Journal Article
Closed access
ABAnna Binkiewicz-Glińska
Anna Binkiewicz-Glińska
JWJolanta Maria Wierzba
Jolanta Maria Wierzba
Edyta SzurowskaEdyta Szurowska
Edyta Szurowska
KRKatarzyna Ruckeman-Dziurdzińska
Katarzyna Ruckeman-Dziurdzińska
SBStanisław Bakuła
Stanisław Bakuła
ARAnna Reńska
Anna Reńska